BPC-157
(BPC-157)Reviewed by Fat Man in the Arena · Updated March 2026
Key Takeaway
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in preclinical studies across tendons, ligaments, muscle, gut, and nervous system tissue.
How it works
BPC-157 promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors, modulates nitric oxide synthesis, and interacts with the dopamine and serotonin systems. It accelerates the healing cascade by recruiting repair cells to injury sites and reducing inflammation.
Benefits
- Accelerated tendon and ligament healing in animal studies
- Gut healing and protection (gastric ulcers, IBD models)
- Muscle tear recovery
- Neuroprotective effects
- Anti-inflammatory properties
- Potential to counteract NSAID damage to the gut
Side effects
- Generally well-tolerated in reported use
- Occasional nausea
- Dizziness (rare)
- Limited human safety data — most research is preclinical
Dosing protocol
Typical Dose
250-500 mcg per day
Frequency
Once or twice daily subcutaneous injection
Cycle Length
4-8 weeks
Can be injected near the injury site or subcutaneously in the abdomen. Oral and topical forms also exist but have less reported efficacy. Not FDA-approved for human use.
Key research
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Current Pharmaceutical Design (2016) — PubMed
Comprehensive review showing BPC-157 heals various gastrointestinal lesions, including ulcers, fistulas, and inflammatory bowel disease in animal models, with consistent cytoprotective and wound-healing effects.
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model
Life Sciences (2019) — PubMed
BPC-157 counteracted NSAID-induced gastrointestinal damage and systemic toxicity in animal models, suggesting protective properties against common pain medication side effects.
Frequently asked questions
No. BPC-157 is not FDA-approved for any human use. It is classified as a research compound. All published studies are preclinical (animal models). While many people report using BPC-157 for injury recovery, no human clinical trials have been completed as of 2026.
Compare BPC-157
Stacks with BPC-157
Goals
Related peptides
Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide.
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.